Lifotronic(688389)2024-07-05 09:52Group 1: Company Overview - Shenzhen Pumen Technology Co., Ltd. adopts a multi-business platform and multi-market development strategy due to the diverse segments within the medical device industry [2] - The company operates in two main business areas: in vitro diagnostics and treatment & rehabilitation, with specific product lines for each [2][3] Group 2: Business Strategy - The company emphasizes the importance of existing technical accumulation and performance support for new business expansions, ensuring synergy in R&D and marketing [3] - Independent management divisions are established for each product line, supported by a public support platform for business and technical development [3] Group 3: Market Potential - The glycosylated hemoglobin (HbA1c) testing market is expected to grow significantly due to the increasing number of diabetes patients and heightened health awareness [3] - The company has developed a series of glycosylated hemoglobin analyzers that cover a wide customer base, enhancing its market presence [3] Group 4: Product Advantages - High-Performance Liquid Chromatography (HPLC) is highlighted as a mainstream technology for glycosylated hemoglobin testing due to its accuracy and ability to indicate the presence of variant hemoglobin [3] - The company's H100Plus analyzer features rapid separation of variants and user-friendly operation, positioning it competitively in the market [3]